Archive for the 'Acid Reflux/GERD' Category

Restech Dx-pH Measurement System Proven To Facilitate Accurate Measurement Of Acid Exposure In Patients With Reflux Related Symptoms

Thursday, August 28th, 2008

Recently, Respiratory Technology Corporation (dba Restech) announced that the Restech Dx-pH Measurement System was part of a study to accurately measure pharyngeal acid exposure conducted by the Advanced Esophageal Function Laboratory of the University of Southern California (USC). The study, 24-hour Pharyngeal pH Measurement©, was conducted under the direction of Tom R.

Share this article These icons link to social bookmarking sites where readers can share and discover new web pages.
  • YahooMyWeb
  • Google
  • bodytext
  • del.icio.us
  • Facebook
  • Technorati
  • Furl

Proton Pump Inhibitors Increase Risk Of Bone Fractures

Wednesday, August 13th, 2008

Patients who use proton pump inhibitors for 7 or more years to treat reflux, peptic ulcers and other conditions are at greater risk of osteoporosis-related fractures, according to this large observational study, http://www.cmaj.ca/press/pg319.pdf, of 15,792 patients published in CMAJ.

Share this article These icons link to social bookmarking sites where readers can share and discover new web pages.
  • YahooMyWeb
  • Google
  • bodytext
  • del.icio.us
  • Facebook
  • Technorati
  • Furl

Pre-Cancerous Condition Linked To Chronic Acid Reflux Faces Several Hurdles

Friday, August 8th, 2008

A pre-cancerous condition linked to chronic acid reflux often gets overlooked. Can the medical community do a better job intervening? Researchers from the Hutchinson-MRC Research Centre in Cambridge think so. In a review published in the inaugural issue of Disease Models & Mechanisms (DMM), http://dmm.biologists.

Share this article These icons link to social bookmarking sites where readers can share and discover new web pages.
  • YahooMyWeb
  • Google
  • bodytext
  • del.icio.us
  • Facebook
  • Technorati
  • Furl

Compliance To Proton Pump Inhibitors Reduces Costs

Wednesday, July 30th, 2008

A new study reveals that patients with gastroesophageal reflux disease (GERD) who receive proton pump inhibitor (PPI) drugs require fewer health care services and incur lower costs if they conform to the recommended usage frequency.

Share this article These icons link to social bookmarking sites where readers can share and discover new web pages.
  • YahooMyWeb
  • Google
  • bodytext
  • del.icio.us
  • Facebook
  • Technorati
  • Furl